Mereo BioPharma Group Plc (MREO)
0.2978
-0.02
(-5.52%)
USD |
NASDAQ |
Oct 13, 14:04
Mereo BioPharma Group Total Return Level : 0.3152 for Oct. 12, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 12, 2026 | 0.3152 |
| October 09, 2026 | 0.3499 |
| October 08, 2026 | 0.3752 |
| October 07, 2026 | 0.3528 |
| October 06, 2026 | 0.3501 |
| October 05, 2026 | 0.388 |
| October 02, 2026 | 0.3798 |
| October 01, 2026 | 0.3669 |
| September 30, 2026 | 0.402 |
| September 29, 2026 | 0.3732 |
| September 28, 2026 | 0.37 |
| September 25, 2026 | 0.37 |
| September 24, 2026 | 0.3375 |
| September 23, 2026 | 0.3403 |
| September 22, 2026 | 0.3163 |
| September 21, 2026 | 0.2901 |
| September 18, 2026 | 0.303 |
| September 17, 2026 | 0.2901 |
| September 16, 2026 | 0.266 |
| September 15, 2026 | 0.285 |
| September 14, 2026 | 0.28 |
| September 11, 2026 | 0.28 |
| September 10, 2026 | 0.2446 |
| September 09, 2026 | 0.2425 |
| September 08, 2026 | 0.2546 |
| Date | Value |
|---|---|
| September 04, 2026 | 0.25 |
| September 03, 2026 | 0.2722 |
| September 02, 2026 | 0.2672 |
| September 01, 2026 | 0.2767 |
| August 31, 2026 | 0.2668 |
| August 28, 2026 | 0.2525 |
| August 27, 2026 | 0.272 |
| August 26, 2026 | 0.278 |
| August 25, 2026 | 0.2816 |
| August 24, 2026 | 0.2895 |
| August 21, 2026 | 0.2904 |
| August 20, 2026 | 0.2933 |
| August 19, 2026 | 0.3115 |
| August 18, 2026 | 0.313 |
| August 17, 2026 | 0.3077 |
| August 14, 2026 | 0.3189 |
| August 13, 2026 | 0.3077 |
| August 12, 2026 | 0.3029 |
| August 11, 2026 | 0.3055 |
| August 10, 2026 | 0.2724 |
| August 07, 2026 | 0.2963 |
| August 06, 2026 | 0.3059 |
| August 05, 2026 | 0.3035 |
| August 04, 2026 | 0.3221 |
| August 03, 2026 | 0.3155 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Biodexa Pharmaceuticals Plc | 0.3832 |
| NuCana Plc | 1.08 |
| BioNTech SE | 97.13 |
| Silence Therapeutics Plc | 3.85 |
| Autolus Therapeutics Plc | 1.74 |